Schedule‐dependent Efficacy of Camptothecins in Models of Human Cancera
- 17 December 1996
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 803 (1) , 188-201
- https://doi.org/10.1111/j.1749-6632.1996.tb26388.x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumorsCancer Chemotherapy and Pharmacology, 1995
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT‐11 and Its Active Metabolite SN‐38Japanese Journal of Cancer Research, 1995
- Surgery and radiation therapy in the treatment of soft tissue sarcomas of extremitiesAnnals of Oncology, 1992
- p Value Adjustments for Multiple Tests in Multivariate Binomial ModelsJournal of the American Statistical Association, 1989
- Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in miceCancer Chemotherapy and Pharmacology, 1988
- Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivoCancer Chemotherapy and Pharmacology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958